13F
中

GEHC GE HEALTHCARE TECHNOLOGY

2026Q1 · CUSIP 36266G107 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
1,254
Δ holders QoQ
-69
Breadth percentile
Top 98%
Whale holders
308
Δ whales
+5
Inst. holding value
$26.9B
New positions
126
Closed positions
195
Price momentum (1Q)
-24.6%
Put / Call
19/24

Breadth history (34 quarters)

2022Q3: Δ+0 · h=1 2022Q4: Δ+40 · h=41 2023Q1: Δ+1007 · h=1048 2023Q2: Δ+62 · h=1110 2023Q3: Δ-17 · h=1093 2023Q4: Δ+76 · h=1169 2024Q1: Δ+71 · h=1240 2024Q2: Δ-36 · h=1204 2024Q3: Δ+54 · h=1258 2024Q4: Δ+59 · h=1317 2025Q1: Δ+36 · h=1353 2025Q2: Δ-51 · h=1302 2025Q3: Δ-36 · h=1266 2025Q4: Δ+57 · h=1323 2026Q1: Δ-69 · h=1254 2022Q3: holders=1 2022Q4: holders=41 2023Q1: holders=1048 2023Q2: holders=1110 2023Q3: holders=1093 2023Q4: holders=1169 2024Q1: holders=1240 2024Q2: holders=1204 2024Q3: holders=1258 2024Q4: holders=1317 2025Q1: holders=1353 2025Q2: holders=1302 2025Q3: holders=1266 2025Q4: holders=1323 2026Q1: holders=1254 -1007 -503.5 +0 +503.5 +1007 07111421 22Q322Q423Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 9 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 8% -24.6% —
2025Q1 Top 5% +1.2% -3.3%
2024Q4 Top 8% -21.1% -20.1%
2024Q3 Top 3% +10.2% -16.0%
2024Q1 Top 2% +4.6% -0.1%
2023Q4 Top 6% -4.8% -0.4%
2023Q2 Top 2% +2.2% +21.3%
2023Q1 Top 0% -14.8% -10.8%
2022Q4 Top 9% +12.4% -3.5%

Options Sentiment

Put holders
19
QoQ: -1
Call holders
24
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
14.7
EPS (TTM)
$4.17
EPS YoY
-12.4%
Revenue (TTM)
$21.0B
Revenue YoY
+6.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $4.5B 2022-09-30: $4.6B 2022-12-31: $4.9B 2023-03-31: $4.7B 2023-06-30: $4.8B 2023-09-30: $4.8B 2023-12-31: $5.2B 2024-03-31: $4.7B 2024-06-30: $4.8B 2024-09-30: $4.9B 2024-12-31: $5.3B 2025-03-31: $4.8B 2025-06-30: $5.0B 2025-09-30: $5.1B 2025-12-31: $5.7B 2026-03-31: $5.1B 2022-06-30: EPS 1.07 2022-09-30: EPS 1.07 2022-12-31: EPS 1.22 2023-03-31: EPS 0.41 2023-06-30: EPS 0.91 2023-09-30: EPS 0.82 2023-12-31: EPS 0.89 2024-03-31: EPS 0.81 2024-06-30: EPS 0.93 2024-09-30: EPS 1.02 2024-12-31: EPS 1.58 2025-03-31: EPS 1.23 2025-06-30: EPS 1.06 2025-09-30: EPS 0.98 2025-12-31: EPS 1.28 2026-03-31: EPS 0.85 0B 2.8B 5.7B $B 0.00 0.87 1.74 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 21 2023-03-31: PE 21.22023-06-30: PE 19.52023-09-30: PE 21.32023-12-31: PE 28.32024-03-31: PE 23.82024-06-30: PE 24.52024-09-30: PE 22.32024-12-31: PE 21.22025-03-31: PE 15.32025-06-30: PE 152025-09-30: PE 15.12025-12-31: PE 17.62026-03-31: PE 14.6 13 21 30 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)